0001209191-23-049031.txt : 20230911
0001209191-23-049031.hdr.sgml : 20230911
20230911193835
ACCESSION NUMBER: 0001209191-23-049031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230909
FILED AS OF DATE: 20230911
DATE AS OF CHANGE: 20230911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loewy Caroline M
CENTRAL INDEX KEY: 0001367451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 231248781
MAIL ADDRESS:
STREET 1: 300 ELLIOTT AVE WEST
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98119-4114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-09
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001367451
Loewy Caroline M
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
1
0
0
0
0
Stock Option (Right to Buy)
0.646
2023-09-09
4
A
0
40000
0.00
A
2033-09-08
Common Stock
40000
40000
D
The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on September 9, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date.
/s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
2023-09-11